A Study in Adolescent Females to Explore Cytomegalovirus Infection

NACompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

October 5, 2012

Primary Completion Date

April 8, 2017

Study Completion Date

April 8, 2017

Conditions
Infections, Cytomegalovirus
Interventions
PROCEDURE

Blood collection

Samples collected at Months 0, 4, 8, 12, 16, 20, 24, 28, 32, and 36.

PROCEDURE

Urine collection

Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36.

PROCEDURE

Saliva collection

Samples collected at Months 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, and 36.

Trial Locations (5)

35233

GSK Investigational Site, Birmingham

49127

GSK Investigational Site, Stevensville

62900

GSK Investigational Site, Jojutla

90220

GSK Investigational Site, Oulu

00260

GSK Investigational Site, Helsinki

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01691820 - A Study in Adolescent Females to Explore Cytomegalovirus Infection | Biotech Hunter | Biotech Hunter